ArticleAnnals of hematology2022

Autologous hematopoietic stem cell transplantation followed by interleukin-2 for adult acute myeloid leukemia patients with favorable or intermediate risk after complete remission.

Qiang Zeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.